Presentation The Structural Heart Disease Summit 2018 The Goal of FMR Treatment: Reduction or Elimination of MR? Presenter: Randall C. Starling June 21, 2018 REGISTER for free or LOG IN to view this content Structural Heart Presentation The Structural Heart Disease Summit 2018 Mitral Valve Up Next Presentation The Structural Heart Disease Summit 2018 Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future! Presenter: Mathew Williams June 21, 2018 More slides + Presentation The Structural Heart Disease Summit 2018 Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain! Presenter: Patrick M. McCarthy June 21, 2018 Presentation The Structural Heart Disease Summit 2018 Optimal Surgical Technique to Prevent Recurrent MR After Mitral Valve Repair Presenter: David H. Adams June 21, 2018 We Recommend
Presentation The Structural Heart Disease Summit 2018 Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future! Presenter: Mathew Williams June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain! Presenter: Patrick M. McCarthy June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Optimal Surgical Technique to Prevent Recurrent MR After Mitral Valve Repair Presenter: David H. Adams June 21, 2018